Correlates of Blood Pressure Awareness, Treatment, and Control Among Adults 50 Years or Older by HIV Status in Northwestern Tanzania.


Journal

Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982

Informations de publication

Date de publication:
08 2022
Historique:
accepted: 14 03 2022
pubmed: 7 4 2022
medline: 10 8 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

The objective of this study was to describe the increasing incidence and risk of cardiovascular disease among persons living with HIV (PLWH) in Sub-Saharan Africa. We also used data to compare hypertension (a common NCD among PLWH) outcomes between PLWH and HIV-uninfected individuals among older adults in Northwestern Tanzania. Hypertension is increasingly common in Sub-Saharan Africa and a leading cause of cardiovascular disease for PLWH. Among those with hypertension, PLWH have a 50% higher risk of incident myocardial infarction compared to the general population. In response to the rising incidence of these non-communicable diseases (NCDs) among PLWH, recently, the Joint United Nations Program on HIV/AIDS supported the integration of NCD care into routine clinical care for HIV. However, data are lacking on levels of awareness of hypertension status, diagnosis, and antihypertensive medication adherence. Given the higher likelihood of elevated blood pressure among PLWH, there is an urgent need to implement interventions to improve blood pressure control in this population. Researchers should evaluate treatment barriers at multiple levels including health system, healthcare providers, and patients' level and tailor evidence-based interventions to increase achievement of blood pressure control for PLWH.

Identifiants

pubmed: 35384578
doi: 10.1007/s11906-022-01188-3
pii: 10.1007/s11906-022-01188-3
pmc: PMC9357024
mid: NIHMS1798186
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-266

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL159052
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW010138
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142099
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI064518
Pays : United States

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Int J Health Sci (Qassim). 2017 Sep-Oct;11(4):47-52
pubmed: 29085268
Am Fam Physician. 2016 Feb 15;93(4):300-2
pubmed: 26926818
AIDS. 2018 Jul 31;32(12):1563-1569
pubmed: 29762172
Am J Hypertens. 2014 Feb;27(2):222-8
pubmed: 24077828
J Hum Hypertens. 2013 Jun;27(6):374-80
pubmed: 23235367
Clin Infect Dis. 2014 Jan;58(1):121-9
pubmed: 24065316
Am J Cardiol. 2012 Oct 15;110(8):1078-84
pubmed: 22762716
Curr Hypertens Rep. 2019 Aug 26;21(10):75
pubmed: 31451940
Lancet HIV. 2020 Apr;7(4):e279-e293
pubmed: 32243826
BMC Med. 2014 Jul 29;12:125
pubmed: 25070128
PLoS One. 2018 Mar 29;13(3):e0194940
pubmed: 29596462
AIDS. 2018 Jul 1;32 Suppl 1:S33-S42
pubmed: 29952788
BMC Cardiovasc Disord. 2013 Aug 02;13:54
pubmed: 23915151
Diabet Med. 1994 Nov;11(9):830-5
pubmed: 7705018
Hypertension. 2013 Dec;62(6):988-94
pubmed: 24060895
Endocr Dev. 2016;31:1-27
pubmed: 26824869
J Clin Hypertens (Greenwich). 2016 Mar;18(3):232-9
pubmed: 26337797
Trop Med Int Health. 2017 Aug;22(8):926-937
pubmed: 28544500
BMC Infect Dis. 2009 Feb 18;9:19
pubmed: 19226452
Diabet Med. 1994 Aug-Sep;11(7):705-8
pubmed: 7955999
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1493-1495
pubmed: 30259656
J Hypertens. 2003 Jul;21(7):1377-82
pubmed: 12817187
Am Health Drug Benefits. 2008 Nov;1(9):39-48
pubmed: 25126264
J Hum Hypertens. 2016 Jun;30(6):355-62
pubmed: 26446389
Int J Epidemiol. 2013 Dec;42(6):1754-71
pubmed: 24415610
BMC Health Serv Res. 2019 Jul 31;19(1):537
pubmed: 31366384
Am Heart J. 2019 Mar;209:79-87
pubmed: 30685678
Lancet Glob Health. 2014 May;2(5):e285-92
pubmed: 24818084
J Public Health Res. 2014 Apr 03;3(1):99
pubmed: 25170505
J Am Heart Assoc. 2017 Nov 14;6(11):
pubmed: 29138182
BMC Public Health. 2016 Sep 21;16(1):1002
pubmed: 27655406
Front Cardiovasc Med. 2020 Apr 07;7:49
pubmed: 32318584
Curr Hypertens Rep. 2013 Jun;15(3):134-6
pubmed: 23536128

Auteurs

Charles Muiruri (C)

Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St., Suite 210, Durham, NC, 27701, USA. charles.muiruri@duke.edu.
Duke Global Health Institute, Duke University, Durham, NC, USA. charles.muiruri@duke.edu.
Kilimanjaro Christian Medical University College, Moshi, Tanzania. charles.muiruri@duke.edu.

Bahati Wajanga (B)

Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Department of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.

Christine Kim (C)

Department of Health Policy and Management, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.

Brandon A Knettel (BA)

Duke Global Health Institute, Duke University, Durham, NC, USA.
Duke University School of Nursing, Durham, NC, USA.

Carl J Mhina (CJ)

Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St., Suite 210, Durham, NC, 27701, USA.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.

John A Bartlett (JA)

Duke Global Health Institute, Duke University, Durham, NC, USA.
Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Jamal J Msangi (JJ)

Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.

Msabah A Msabah (MA)

Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.

Helene Vilme (H)

Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St., Suite 210, Durham, NC, 27701, USA.

Samuel Kalluvya (S)

Department of Internal Medicine, Bugando Medical Centre, Mwanza, Tanzania.
Department of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH